BioWorld. Link to homepage.
BioWorld
BioWorld Science
BioWorld Asia
Data Snapshots
Biopharma
Medical technology
Infographics: Dynamic digital data analysis
Index insights
NME Digest
Special reports
Infographics: Dynamic digital data analysis
Trump administration impacts
Med-tech outlook 2026
Under threat: mRNA vaccine research
BioWorld at 35
Biopharma M&A scorecard
Bioworld 2025 review
BioWorld MedTech 2025 review
BioWorld Science 2025 review
Women's health
China's GLP-1 landscape
PFA re-energizes afib market
China CAR T
Alzheimer's disease
Coronavirus
More reports can be found here
BioWorld. Link to homepage.
Sign In
Sign Out
My Account
Subscribe
BioWorld - Saturday, May 9, 2026
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Feb. 20, 2012
View Archived Issues
Takeda Pharmaceutical offers overview of third quarter fiscal 2011
Read More
BiondVax's phase II flu vaccine trial meets primary safety endpoint
Read More
Debiopharm commences phase Ib expansion study of Debio-0932
Read More
Hanmi and AngioLab enter licensing agreement
Read More
Studies point to benefit of sonothrombolysis after stroke
Read More
New antiviral agents disclosed by Alla Chem
Read More
Alla Chem presents new androgen receptor antagonists
Read More
Latvian company patents novel agents for influenza
Read More
New protein kinase inhibitors synthesized by Chinese team
Read More
Trials indicate ipilimumab can be administered with cancer vaccines
Read More
Novel tissue engineering scaffolds tested in vivo
Read More
Hyundai Pharmaceutical discloses new GPR119 receptor agonists
Read More
Novartis to revise product information for Rasilez in the E.U.
Read More
GlaxoSmithKline provides regulatory update on Tykerb/Tyverb
Read More
NeuroPhage Pharmaceuticals receives funding from Michael J. Fox Foundation
Read More
GlaxoSmithKline receives CHMP opinion on Nimenrix
Read More
Collaborating Japanese universities identify new potential target for cancer therapy
Read More
Gilead Sciences reports on ELECTRON trial
Read More
New approval for Zelboraf
Read More
Dainippon Sumitomo seeks line extension for Amlodin in Japan
Read More
EMA committee recommends conditional approval of Pixuvri
Read More
TCG Lifesciences chooses preclinical development candidate
Read More
CHMP recommends approval of Byetta line extension
Read More
FDA approves first medical therapy for endogenous Cushing's syndrome
Read More
